Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02392390Completed
Open-label, single-arm trial of methyl aminolevulinate in leg ulcer, sponsored by CHU Nîmes. Primary endpoint: Percentage of commensal or weak virulence potential bacteria among all bacteria species isolated per sample. Started Oct 2015; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02392390.